glp-1 epilepsy A preliminary study of people with diabetes suggests that use of glucose-lowering drugs may be linked to a lower risk of developing epilepsy. The study was published on December 10, 2025 Neuroprotective effects of glucagon-like peptide-1

Inspired by the intriguing ECL1 conformation of GLP-2R, we performed structural comparison of ECL1 across class B GPCRs to unveil its functionality (Fig

MHRA-approved options include orlistat (prescription and over the counter), semaglutide (Wegovy, supported by NICE TA875), and liraglutide (Saxenda, supported by NICE TA664)

According to medical experts, reach out to your dentist if you notice new sensitivity in your teeth, bleeding gums, bad breath that wont go away, or sudden changes like loose teeth or pieces breaking off

Ecology , 58/4: 750-762

However, contact your healthcare provider if cold intolerance is accompanied by severe fatigue, hair loss, cognitive changes, or other symptoms that might indicate thyroid dysfunction or other medical conditions requiring evaluation

Its progressive dysfunction with agedecline in NAD+, accumulation of ROS, reduction in mitochondrial biogenesisis a central mechanism of aging and degenerative diseases